Institutional Review Board for
the Protection of Human Subjects (IRB) Policy
All research involving human subjects requires the approval of the Institutional Review Board for the Protection of Human Subjects. No project may begin without an IRB approval. The IRB also has general responsibility to oversee institutional policies, practices and reporting of the emergency use of unapproved investigational drugs or devices that would typically require an IND (Investigational New Drug approval) or IDE (Investigational Device Exception). Information and protocol application forms can be obtained online or from the IRB office, Rrom 1254, Weiskotten Hall (phone: 464-4317).
On persons having a faculty appointment at Upstate may be the Principal Investigator (PI) on an IRB protocol. Projects taking place at multiple sites (e.g., the VA Medical Center or Crouse Hospital) will require approval by the IRBs at those sites in addition to Upstate. SUNY Upstate Medical University holds a Multiple Project Assurance (M-1303), which expires on 4/30/03. This assurance is Upstate's guarantee that all research conducted at Upstate or by persons paid by Upstate is in full compliance with federal regulations. Failure to adhere to these regulations could result in suspension of all federal funding for research at the campus, even if the project in question is funded through intramural and/or non-federal funds.
Questions regarding IRB policy and requirements should be directed to:
IRB Office
Room: 1254 Weiskotten Hall
Phone: 315 464-4317
 GENERAL POLICIES
| 
